SC 13D/A:超過5%持股股東披露文件(修正)-1315 Capital II, L.P.(68%),1315 Capital Management II, LLC(68%)
SC 13D/A:超過5%持股股東披露文件(修正)-Ampersand 2018 Limited Partnership(76%),AMP-18 Management Company Limited Partnership(76%)等
D:發行公告
4:持股變動聲明-股東 1315 Capital II, L.P.
4:持股變動聲明-股東 Ampersand 2018 Limited Partnership
Interpace Biosciences Inc | SC 13G/A:超過5%持股股東披露文件(修正)-Douglas M. Singer(5.78%)
Interpace Biosciences Inc | 4:持股變動聲明-高管 McCarthy Christopher
Interpace Biosciences Inc | 4:持股變動聲明-首席財務官 McCarthy Christopher
Interpace Biosciences Inc | 3:首次持股聲明-高管 McCarthy Christopher
Interpace Biosciences Inc | SC 13G/A:超過5%持股股東披露文件(修正)-Douglas M. Singer(8.32%)
Interpace Biosciences Inc | SC 13D/A:超過5%持股股東披露文件(修正)-Peter H. Kamin(18.6%)
Interpace Biosciences Inc | SC 13D/A:超過5%持股股東披露文件(修正)-Peter H. Kamin(18.6%)
Interpace Biosciences Inc | 4:持股變動聲明
Interpace Biosciences Inc | SC 13D/A:超過5%持股股東披露文件(修正)
Interpace Biosciences Inc | 4:持股變動聲明
Interpace Biosciences Inc | 4:持股變動聲明
Interpace Biosciences Inc | 3:首次持股聲明
Interpace Biosciences Inc | SC 13D:超過5%持股股東披露文件
Interpace Biosciences Inc | SC 13G/A:超過5%持股股東披露文件(修正)
Interpace Biosciences Inc | 4:持股變動聲明